We are live on
!
Find out more
VCM
Versant Capital Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
34.21%
This Fund
S&P 500
This Quarter
Est. Return
+13.52%
1 Year Est. Return
+34.21%
3 Year Est. Return
+82.39%
5 Year Est. Return
+89.4%
10 Year Est. Return
+245.39%
AUM
$1.12B
AUM Growth
+$101M
(+10%)
Cap. Flow
+$19.1M
Cap. Flow
% of AUM
1.71%
Top 10 Holdings %
Top 10 Hldgs %
31.56%
Holding
2,873
New
96
Increased
1,181
Reduced
859
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXUV
Dimensional US Vector Equity ETF
DXUV
|
+$8.37M |
| 2 |
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
|
+$7.66M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$6.75M |
| 4 |
DXIV
Dimensional International Vector Equity ETF
DXIV
|
+$4.35M |
| 5 |
Dimensional Emerging Markets Value ETF
DFEV
|
+$2.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$2.11M |
| 2 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$2.02M |
| 3 |
Vanguard Total Stock Market ETF
VTI
|
+$1.88M |
| 4 |
CoreCivic
CXW
|
+$1.84M |
| 5 |
Apple
AAPL
|
+$1.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.06% |
| 2 | Financials | 7.05% |
| 3 | Industrials | 6.04% |
| 4 | Consumer Discretionary | 4.74% |
| 5 | Healthcare | 4.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Enovis
ENOV
$1.56B
| $26.8K | ﹤0.01% |
1,294
-254
| -16% | -$5.99K |
|
1777
DoubleVerify
DV
$1.62B
| $26.7K | ﹤0.01% |
2,466
+407
| +20% | +$4.19K |
|
1778
Pennant Group
PNTG
$1.43B
| $26.7K | ﹤0.01% |
723
+25
| +4% | +$817 |
|
1779
Copart
CPRT
$25.9B
| $26.7K | ﹤0.01% |
947
+498
| +111% | +$16.1K |
|
1780
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.9B
| $26.7K | ﹤0.01% |
683
| – | – |
|
1781
Brighthouse Financial
BHF
$3.63B
| $26.6K | ﹤0.01% |
421
+104
| +33% | +$6.47K |
|
1782
Suncor Energy
SU
$77.7B
| $26.5K | ﹤0.01% |
493
+398
| +419% | +$25.2K |
|
1783
Champion Homes
SKY
$4.48B
| $26.4K | ﹤0.01% |
300
-27
| -8% | -$2.07K |
|
1784
Bio-Rad Laboratories Class A
BIO
$8.42B
| $26.4K | ﹤0.01% |
90
-106
| -54% | -$30.1K |
|
1785
Stride
LRN
$3.69B
| $26.4K | ﹤0.01% |
306
-160
| -34% | -$14.7K |
|
1786
HealthEquity
HQY
$7.91B
| $26.4K | ﹤0.01% |
292
-161
| -36% | -$13.6K |
|
1787
Pacira BioSciences
PCRX
$1.02B
| $26.3K | ﹤0.01% |
1,036
| – | – |
|
1788
Hackett Group
HCKT
$245M
| $26.3K | ﹤0.01% |
2,439
-5,744
| -70% | -$67.1K |
|
1789
DigitalBridge
DBRG
$2.94B
| $26.2K | ﹤0.01% |
1,661
| – | – |
|
1790
FB Financial Corp
FBK
$2.95B
| $26.2K | ﹤0.01% |
473
-135
| -22% | -$7.25K |
|
1791
Tyra Biosciences
TYRA
$1.82B
| $26.2K | ﹤0.01% |
819
| – | – |
|
1792
La-Z-Boy
LZB
$1.59B
| $26.2K | ﹤0.01% |
652
+413
| +173% | +$14.9K |
|
1793
Virtu Financial
VIRT
$5.2B
| $26.2K | ﹤0.01% |
439
| – | – |
|
1794
Coeur Mining
CDE
$15.6B
| $26.1K | ﹤0.01% |
1,601
+820
| +105% | +$14.9K |
|
1795
BILL Holdings
BILL
$4.33B
| $26.1K | ﹤0.01% |
722
+430
| +147% | +$15.8K |
|
1796
Vanguard Mid-Cap Value ETF
VOE
$23.7B
| $26.1K | ﹤0.01% |
132
| – | – |
|
1797
Werner Enterprises
WERN
$2.54B
| $26.1K | ﹤0.01% |
598
-141
| -19% | -$5.31K |
|
1798
Titan Machinery
TITN
$466M
| $26K | ﹤0.01% |
1,232
| – | – |
|
1799
Pool Corp
POOL
$6.7B
| $26K | ﹤0.01% |
121
-627
| -84% | -$125K |
|
1800
Hims & Hers Health
HIMS
$6.5B
| $25.9K | ﹤0.01% |
748
+665
| +801% | +$17.9K |
|
Similar funds
FLAM
AIM
MTCM
CNC
NOSC
RIM
ACG
C
Versant Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Versant Capital Management held 2,873 positions worth $1.12B, up 10% from $1.01B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Versant Capital Management's Q2 2026 filing shows 96 new, 1,181 increased, 859 reduced and 128 closed positions. Its largest new stake was AstraZeneca: 7,263 shares worth $1.36M. The largest sale was iShares 3-7 Year Treasury Bond ETF, an estimated $2.11M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Industrials.
- Versant Capital Management's largest Q2 2026 buy was AstraZeneca: 7,263 shares worth $1.36M.
- Versant Capital Management added most to Dimensional US Vector Equity ETF in Q2 2026, an estimated $8.37M increase.
- Versant Capital Management's biggest Q2 2026 reduction was iShares 3-7 Year Treasury Bond ETF, cutting an estimated $2.11M.
- Versant Capital Management fully exited iShares 5-10 Year Investment Grade Corporate Bond ETF in Q2 2026, selling an estimated $2.02M.
- Versant Capital Management's ten largest holdings make up 32% of its $1.12B portfolio in Q2 2026.
- Versant Capital Management opened 96 new positions and closed 128 in Q2 2026.
- Versant Capital Management's portfolio value rose 10% quarter-over-quarter to $1.12B.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.